Abstract
The general anaesthetic propofol shows promise in protecting normal hearts against various cardiac insults, but little is known about its cardioprotective potential in hypertrophic hearts. This study tested the hypothesis that propofol at a clinically relevant dose would enhance functional recovery in hypertrophic hearts following ischaemia. Hypertrophic hearts from spontaneously hypertensive rats and hearts from their normotensive controls, Wistar Kyoto Rats, were equilibrated in the working mode prior to global normothermic ischaemia. Reperfusion commenced with 10 min in Langendorff mode, followed by 30-min working reperfusion. Functional performance was measured throughout the working mode, whilst reperfusion damage was assessed from myocardial troponin I release during Langendorff reperfusion. Where used, 4 μg/ml propofol was added 10 min before ischaemia and was washed out 10 min into working reperfusion. An additional protocol investigated recovery of hearts protected by normothermic hyperkalaemic cardioplegic arrest. Following 20-min ischaemia, reperfusion damage was significantly worse in hypertrophic hearts compared to normal hearts, whilst addition of propofol to hypertrophic hearts significantly improved the aortic flow (31 ± 5.8 vs. 11.6 ± 2.0 ml/min, n = 6–7 ± SE, p < 0.05). Propofol also conferred significant protection following 30-min ischaemia where the recovery of cardiac output and stroke volume was similar to that for cardioplegia alone. Incubation with propofol improved the NADH/NAD+ ratio in freshly isolated cardiomyocytes from hypertrophic hearts, suggesting possible improvements in metabolic flux. These findings suggest that propofol at the clinically relevant dose of 4 μg/ml is as effective as cardioplegic arrest in protecting hypertrophic hearts against ischaemia–reperfusion.
Similar content being viewed by others
References
Afanas’ev I (2011) ROS and RNS signaling in heart disorders: could antioxidant treatment be successful? Oxidative Med Cell Longev. doi:10.115/2011/293769
Allard MF (2004) Energy metabolism in cardiac hypertrophy. Curr Hypertens Rep 6:430–435
Brooksby P, Levi A, Jones JV (1993) The electrophysiological characteristics of hypertrophied ventricular myocytes from the spontaneously hypertensive rat. J Hypertens 11:611–622
Corcoran TB, Sakamoto AEH, O’Shea A, O’Callaghan-Enright S, Shorten GD (2006) The effects of propofol on neutrophil function, lipid peroxidation and inflammatory response during elective coronary artery bypass grafting in patients with impaired ventricular function. Br J Anaesth 97:825–831
Friddle CJ, Koga T, Rubin EM, Rubin J (2000) Expression profiling reveals distinct sets of genes altered during induction and regression of cardiac hypertrophy. Proc Natl Acad Sci USA 97:6745–6750
Garcia-Dorado D (2004) Myocardial reperfusion injury: a new view. Cardiovasc Res 61:363–364
Green TR, Bennett SR, Nelson VM (1994) Specificity and properties of propofol as an antioxidant free radical scavenger. Toxicol Appl Pharmacol 129:163–169
Ha JH, Noh HS, Shin IW, Hahm JR, Kim DR (2012) Mitigation of H2O2-induced autophagic cell death by propofol in H9c2 cardiomyocytes. Cell Biol Toxicol 28:19–29
Hochhauser E, Lesham D, Kaminski O, Cheporko Y, Vidne BA, Shainberg A (2007) The protective effect of prior ischaemia reperfusion adenosine A1 or A3 receptor activation in the normal and hypertrophied heart. Interact Cardiovasc Thorac Surg 6:363–368
Imura H, Caputo M, Parry A, Pawade A, Angelini GD, Suleiman M-S (2001) Age-dependent and hypoxia-related differences in myocardial protection during pediatric open heart surgery. Circ 103:1551–1556
Javadov SA, Lim KHH, Kerr PM, Suleiman M-S, Angelini GD, Halestrap AP (2000) Protection of hearts from reperfusion injury by propofol is associated with inhibition of the mitochondrial permeability transition. Cardiovasc Res 45:360–369
Kamada N, Kanaya N, Hirata N, Kimura S, Namiki A (2008) Cardioprotective effects of propofol in isolated ischemia–reperfused guinea pig hearts: role of KATP channels and GSK-3β. Can J Anesth 55:595–605
King N, Lin H, McGivan JD, Suleiman M-S (2004) Aspartate transporter expression and activity in hypertrophic rat heart and ischaemia–reperfusion injury. J Physiol 556:849–858
King N, Lin H, McGivan JD, Suleiman M-S (2006) Expression and activity of the glutamate transporter EAAT2 in cardiac hypertrophy: implications for ischaemia reperfusion injury. Pflügers Arch 452:674–682
Li YC, Ridefelt P, Wiklund L, Bjerneroth G (1997) Propofol induces a lowering of free cytosolic calcium in myocardial cells. Acta Anaesth Scand 41:633–638
Lim KHH, Halestrap AP, Angelini GD, Suleiman M-S (2005) Propofol is cardioprotective in a clinically relevant model of normothermic blood cardioplegic arrest and cardiopulmonary bypass. Exp Biol Med 230:413–420
Pantos C, Mourouzis I, Colekinos DV (2007) Protection of the abnormal heart. Heart Fail Rev 12:319–330
Shao H, Li J, Zhou Y, Ge Z, Fan J, Shao Z, Zeng Y (2008) Dose-dependent protective effect of propofol against mitochondrial dysfunction in ischaemic/reperfused rat heart: role of cardiolipin. Br J Pharmacol 153:1641–1649
Stadnicka A, Contney SJ, Moreno C, Weihrauch D, Bosnjak ZJ, Roman RJ, Stekiel TA (2009) Mechanisms of differential cardiovascular response to propofol in Dahl Salt-Sensitive, Brown Norway, and chromosome 13-substituted consomic rat strains: role of large conductance Ca2+ and voltage-activated potassium channels. J Pharmacol Exp Ther 330:727–735
Stekiel TA, Contney SJ, Roman RJ, Weber CA, Stadnicka A, Bosnjak ZJ, Greene AS, Moreno C (2011) Pharmacogenomic strain differences in cardiovascular sensitivity to propofol. Anesthesiol 115:1192–1200
Stekiel TA, Weber CA, Contney SJ, Bosnjak ZJ (2007) Differences in cardiovascular sensitivity to propofol in a chromosome substitution rat model. Croat Med J 48:312–318
Suleiman M-S, Caputo M, Ascione R, Bryan AJ, Lucchetti V, Gomes WJ, Angelini GD (1998) Metabolic differences between hearts of patients with aortic valve disease and hearts of patients with ischaemic disease. J Mol Cell Cardiol 30:2519–5223
Suleiman M-S, Hancock M, Shukla R, Rajakaruna C, Angelini GD (2011) Cardioplegic strategies to protect the hypertrophic heart during cardiac surgery. Perfusion 26:48–56
Tao X, Lu L-Q, Xu Q, Li S-R, Lin M-T (2009) Cardioprotective effects of anesthetic preconditioning in rats with ischemia–reperfusion injury: propofol versus isoflurane. J Zhejiang Univ Sci B 10:740–747
Venturini A, Ascione R, Lin H, Polesel E, Angelini GD, Suleiman M-S (2009) The importance of myocardial amino acids during ischemia and reperfusion in dilated left ventricle of patients with degenerative mitral valve disease. Mol Cell Biochem 330:63–70
Williams H, King N, Griffiths EJ, Suleiman M-S (2001) Glutamate-loading stimulates metabolic flux and improves cell recovery following chemical hypoxia in isolated cardiomyocytes. Cardiovasc Res 33:2109–2119
Xia ZY, Godin DV, Ansley DM (2003) Propofol enhances ischemic tolerance of middle-aged rat hearts: effects on 15-F-2 t-isoprostane formation and tissue antioxidant capacity. Cardiovasc Res 59:113–121
Xia ZY, Luo T (2004) Sevoflurane or desflurane anesthesia plus postoperative propofol sedation attenuates myocardial injury after coronary surgery in elderly high-risk patients. Anesthesiol 100:1038–1039
Xia W-F, Liu Y, Zhou Q-S, Tang Q-Z, Zou H-D (2011) Comparison of the effects of propofol and midazolam on inflammation and oxidative stress in children with congenital heart disease undergoing cardiac surgery. Yonsei Med J 52:326–332
Xia W-F, Liu Y, Zhou Q-S, Tang Q-Z, Zou H-D (2011) Protective effect of propofol and its relation to postoperation recovery in children undergoing cardiac surgery with cardiopulmonary bypass. Pediatr Cardiol 32:940–946
Acknowledgements
Investigations at the Bristol Heart Institute were supported by the British Heart Foundation. We are also grateful to Mr Mark Ginty and Mrs Hua Lin for technical assistance.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
King, N., Al Shaama, M. & Suleiman, MS. Propofol improves recovery of the isolated working hypertrophic heart from ischaemia–reperfusion. Pflugers Arch - Eur J Physiol 464, 513–522 (2012). https://doi.org/10.1007/s00424-012-1152-5
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00424-012-1152-5